Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Vitamin D and the central nervous system.
I-BET151 selectively regulates IL-6 production.
Spinal cord lesions and disability in Hispanics with multiple sclerosis.
Perspectives of the relationship between IL-7 and autoimmune diseases.
Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis.
A patient's perspective of partnership in the treatment of multiple sclerosis: MS regimes-An orchestrated approach.
Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination.
Ocular side effects of drugs used in the treatment of multiple sclerosis.
Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: special focus on helminth-derived treatments.
ECL1i, d(LGTFLKC), a novel, small peptide that specifically inhibits CCL2-dependent migration.
Labeling mesenchymal cells with DMSA-coated gold and iron oxide nanoparticles: assessment of biocompatibility and potential applications.
Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.
Therapeutic plasma exchange in children with acute autoimmune central nervous system disorders.
Comminuted C2 Articular Pillar Fracture in a Patient With Multiple Sclerosis and Recurrent Falls.
Alerted microglia and the sympathetic nervous system: a novel form of microglia in the development of hypertension.
Optimizing treatment success in multiple sclerosis.
Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles and microRNA Dysregulation.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Modifiable environmental factors in multiple sclerosis.
Predicting outcome in clinically isolated syndrome using machine learning.
Autophagy and neurodegeneration.
Clinically Significant Fatigue: Prevalence and Associated Factors in an International Sample of Adults with Multiple Sclerosis Recruited via the Internet.
Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
Managing patients with neurologic disorders who participate in sports activities.
Oncostatin M protects against demyelination by inducing a protective microglial phenotype.
Pages
« first
‹ previous
…
506
507
508
509
510
511
512
513
514
…
next ›
last »